Get the Stockscreener App
14.93
0.54%
0.0799
Ascentage Pharma Group International Adr stock is traded at $14.93, with a volume of 5,026.
It is up +0.54% in the last 24 hours and down -6.69% over the past month.
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.
See More
Previous Close:
$14.85
Open:
$14.69
24h Volume:
5,026
Relative Volume:
0.72
Market Cap:
$1.39B
Revenue:
$80.00M
Net Income/Loss:
$-172.98M
P/E Ratio:
-7.6883
EPS:
-1.9419
Net Cash Flow:
$-178.54M
1W Performance:
+2.61%
1M Performance:
-6.69%
6M Performance:
-44.89%
1Y Performance:
-59.53%
1-Day Range:
$14.47
$14.93
1-Week Range:
$14.50
$16.07
52-Week Range:
$14.46
$40.47
Ascentage Pharma Group International Adr Stock (AAPG) Company Profile
Name
Ascentage Pharma Group International Adr
Sector
Industry
Phone
-
Address
-
Compare AAPG vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AAPG
Ascentage Pharma Group International Adr
|
14.93 | 1.39B | 80.00M | -172.98M | -178.54M | -1.9419 |
VRTX
Vertex Pharmaceuticals Inc
|
508.46 | 128.88B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
237.99 | 95.01B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
800.59 | 82.42B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
849.61 | 53.43B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
372.06 | 42.09B | 5.76B | 514.49M | 1.10B | 4.4813 |
Ascentage Pharma Group International Adr Stock (AAPG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-26 | Initiated | Citizens | Mkt Outperform |
| Jun-10-26 | Initiated | B. Riley Securities | Buy |
| Apr-24-26 | Initiated | Deutsche Bank | Buy |
| Mar-12-26 | Resumed | BTIG Research | Buy |
| Jan-13-26 | Initiated | Rodman & Renshaw | Buy |
| Dec-04-25 | Initiated | Oppenheimer | Outperform |
| Nov-24-25 | Initiated | Truist | Buy |
| Nov-10-25 | Initiated | BTIG Research | Buy |
| Nov-05-25 | Initiated | Piper Sandler | Overweight |
| Mar-27-25 | Initiated | JP Morgan | Overweight |
View All
Ascentage Pharma Group International Adr Stock (AAPG) Latest News
Ascentage Pharma Group InternationalAmerican Depository Shares (Nasdaq:AAPG) Detailed Stock Data - The Chronicle-Journal
ADARx Pharmaceuticals, Inc. (ADRX) Stock Price & News - Syfe
APi Group (NYSE:APG) Stock Bought Rep. Gilbert Ray Cisneros, Jr. - MarketBeat
If You Invested $1000 In APi Group Stock 5 Years Ago, You Would Have This Much Today - Benzinga
Ascentage Pharma Group International (NASDAQ:AAPG) Sets New 12-Month LowHere's What Happened - MarketBeat
APi Group Corp (APG) Shares Fall 5.5% -- GF Value Says Still Ove - GuruFocus
APi Group Corp Stock (APG) Moved Down by 10.17% on Sep 9: Key Drivers Unveiled - TradingKey
APi Group (NYSE:APG) Trading Down 8.2%Here's What Happened - MarketBeat
APi Group at Jefferies conference: data centers drive growth plan By Investing.com - Investing.com India
APi Group at Jefferies conference: data centers drive growth plan - investing.com
APi Group at Jefferies conference: data centers drive growth plan By Investing.com - Investing.com Canada
APi Group Corporation $APG Shares Bought by Squarepoint Ops LLC - MarketBeat
InMode Ltd. (INMD) Stock Price & News - Syfe
Ascentage Pharma Earnings Call Highlights Pipeline Momentum - TipRanks
Ascentage Pharma Group International (NASDAQ:AAPG) Sees Strong Trading VolumeStill a Buy? - MarketBeat
Public Employees Retirement System of Ohio Buys Shares of 110,762 APi Group Corporation $APG - MarketBeat
Ascentage Pharma Group International (NASDAQ:AAPG) Reaches New 52-Week LowHere's What Happened - MarketBeat
APi Group Corporation $APG is Pelham Capital Ltd.'s 7th Largest Position - MarketBeat
APi Group Corporation $APG Position Lessened by Spyglass Capital Management LLC - MarketBeat
65,700 Shares in APi Group Corporation $APG Purchased by Aubrey Capital Management Ltd - MarketBeat
Ancora Advisors LLC Boosts Stock Holdings in APi Group Corporation $APG - MarketBeat
Ascentage Pharma Group International (NASDAQ:AAPG) Trading Down 6%Should You Sell? - MarketBeat
APi Group Corporation $APG Shares Acquired by JNBA Financial Advisors - MarketBeat
Oarsman Capital Inc. Boosts Stake in APi Group Corporation $APG - MarketBeat
Kerrisdale Advisers LLC Invests $1.39 Million in APi Group Corporation $APG - MarketBeat
APi Group Corp (APG) Stock Down 3.8% but Still Overvalued -- GF Score: 76/100 - GuruFocus
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Up 6%Here's What Happened - MarketBeat
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap UpStill a Buy? - MarketBeat
Ascentage Pharma Group InternationalUnsponsored ADR (NASDAQ:AAPG) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
$100 Invested In APi Group 5 Years Ago Would Be Worth This Much TodayAPi Group (NYSE:APG) - Benzinga
APi Group Announces Participation in 2026 Jefferies Global Industrials Conference - Yahoo Finance
2,196,689 Shares in APi Group Corporation $APG Acquired by Bank of New York Mellon Corp - MarketBeat
Ascentage Pharma Earnings Call Highlights Pipeline Momentum - theglobeandmail.com
Wall Street Analysts Predict a 160.09% Upside in Ascentage Pharma Group InternationalUnsponsored ADR (AAPG): Here's What You Should Know - Eastern Progress
Ascentage (AAPG) Latest: Declines 1.85% to $17.00 in the Latest Session; the Near-Term Reference Band Stretches From $16.15 to $17.85 in the Current UpdateVolume Gap - dars.gov.et
Ascentage (AAPG) Latest: Declines 1.85% to $17.00 in the Latest Session; the Near-Term Reference Band Stretches From $16.15 to $17.85 in the Current UpdateHigh Low Breadth - dars.gov.et
Ascentage (AAPG) Latest: Declines 1.85% to $17.00 in the Latest Session; the Near-Term Reference Band Stretches From $16.15 to $17.85 in the Current UpdateFundamentals - dars.gov.et
APi Group Corporation (NYSE:APG) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Ascentage Pharma Group International (NASDAQ:AAPG) Trading Down 4.9%Time to Sell? - MarketBeat
Ascentage Pharma Group International H1 Earnings Call Highlights - NewsBreak: Local News & Alerts
Ascentage Pharma Group International H1 Earnings Call Highlights - Yahoo Finance
APi Group Corp (APG) Stock Down 4.3% but Still Overvalued -- GF Score: 76/100 - GuruFocus
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap DownHere's Why - MarketBeat
Here’s How Much You Would Have Made Owning APi Group Stock In The Last 5 Years - Benzinga
Ascentage Pharma Corrects Timing for August 19, 2026 Interim Results Webcast - TipRanks
Handelsbanken Fonder AB Sells 136,796 Shares of APi Group Corporation $APG - MarketBeat
APi Group Corporation (APG) Stock Forecasts - Yahoo Finance
Ascentage Pharma Group International (NASDAQ:AAPG) Sets New 12-Month LowWhat's Next? - MarketBeat
Quantinno Capital Management LP Purchases 30,967 Shares of APi Group Corporation $APG - MarketBeat
Bank of America Corp DE Has $101.78 Million Stock Position in APi Group Corporation $APG - MarketBeat
Ascentage Pharma Group International Adr Stock (AAPG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ascentage Pharma Group International Adr Stock (AAPG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Zhai Yifan | Chief Medical Officer |
May 21 '26 |
Option Exercise |
0.00 |
92,746 |
0 |
405,280 |
| Yang Dajun | Chairman and CEO |
May 21 '26 |
Option Exercise |
0.00 |
92,746 |
0 |
405,280 |
| Yang Dajun | Chairman and CEO |
May 21 '26 |
Option Exercise |
0.00 |
95,575 |
0 |
1,193,569 |
3.78%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):